Strict IGF-1 Control in Acromegaly
NCT02952885
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Acromegaly
Interventions
DRUG:
Pegvisomant
Sponsor
Unity Health Toronto